We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
The Competition and Market Authority (CMA)'s work aims to tackle potentially harmful online selling practices.
Information for pregnant women with singleton (having only one baby) and twin pregnancies who have received a higher-chance result from the combined or quadruple screening test
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Help someone make decisions if they appoint you or if they lack mental capacity - includes using a power of attorney, becoming a deputy and getting a one-off Court of Protection ruling
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How to use A/B testing to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
Find out about the ways people can make certain decisions for you or do certain things on your behalf
How to use a cost utility analysis to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How GBN’s technology selection process for Small Modular Reactors (SMRs) will work.
How to assess a planning application when there are invertebrates on or near a proposed development site.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).